AbbVie | ABBV - Market Capitalization

Stock Price
206.67
Daily Change
-2.17 -1.04%
Monthly
-9.14%
Yearly
10.79%
Q2 Forecast
202.55

AbbVie reported $367.14B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Abbott USD 217.86B 15.25B Dec/2025
ALKERMES USD 4.62B 333M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Coherus Biosciences USD 172M 19M Dec/2025
Eisai JPY 1.31T 140.95B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Infinity Pharmaceuticals USD 0 0 Apr/2026
J&J USD 500.24B 67.44B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 46.41B 13.94B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025
Zoetis USD 55.45B 9.4B Dec/2025